Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Tianyin Pharmaceutical" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Tianyin Pharmaceutical for you to read. Along with our medical data and news we also list Tianyin Pharmaceutical Clinical Trials, which are updated daily. BioPortfolio also has a large database of Tianyin Pharmaceutical Companies for you to search.
CSPC NBP Pharmaceutical, a subsidiary of CSPC Pharmaceutical Group Limited, has signed an equity transfer and capital increase agreement with...Read More... The post M&As this week: CSPC NBP Pharmaceutical, International Finance Corporation, Sun Pharmaceutical appeared first on Pharmaceutical Technology.
AstraZeneca, Janssen Pharmaceutical, Merck and Co., and Roche were among the pharmaceutical firms that voiced their post-Brexit concerns via written...Read More... The post Brexit’s Implications for the UK Pharmaceutical Sector appeared first on Pharmaceutical Technology.
Vice-President Dr. Mahamudu Bawumia has tasked players in the pharmaceutical industry to work toward making Ghana the go-to destination in all things pharmaceutical for the sub-region. "I urge all the players in the pharmaceutical sector, including the private sector, to pull resources together to turn Ghana into a vibrant pharmaceutical research and development and production hub," he said.
The Pharmaceutical industry has seen a decline in M&A deals that have taken place in the last few years. Figure...Read More... The post Pharmaceutical M&A deals decline appeared first on Pharmaceutical Technology.
Chinese pharmaceutical company Sichuan Kelun Pharmaceutical has issued a public offering of 2018’s first-tranche medium-term notes to raise CNY500m ($78.96m). The...Read More... The post Deals this week: Sichuan Kelun Pharmaceutical, Syros Pharmaceuticals, Cerus appeared first on Pharmaceutical Technology.
Pharmaceutical Filtration Market Analysis, by type, by product By Key Companies, by application - Forecast to 2022 Market Synopsis of Pharmaceutical filtration Devices Market: Market Scenario: Globally, Pharmaceutical filtration Devices Market is growing rapidly and it is anticipated to show an exponential growth reaching approximately $23 Billion in 2022. Filtration in pharmaceutical has been use...
Oasmia Pharmaceutical AB (publ) ("Oasmia" or the "Company") a developer of a new generation of drugs within human and veterinary oncology, has agreed to a loan totalling 108 million SEK, of which 7...
SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...
Leading publisher of pharmaceutical,science,technology,journals,advertising,technical,articles,biotechnology,regulatory
Xiangxue Pharmaceutical has raised CNY500m ($75.56m) through the second tranche of a public offering of corporate bonds. The company secured...Read More... The post Deals this week: Xiangxue Pharmaceutical, AstraZeneca, Vanc Pharmaceuticals appeared first on Pharmaceutical Technology.
Collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guideline
BioMarin Pharmaceutical and Sinovac Biotech are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. BioMarin Pharmaceutical has a beta of 1.77, indicating that its share price is 77% more volatile than the S&P 500.
The pharmaceutical industry is highly complex, fast-moving, technical, and specialised. This means that transcription for the pharmaceutical industry must be able to meet the demands of this industry.
Cardinal Health is one of the three leaders in pharmaceutical distribution with AmerisourceBergen and McKesson . CAH operates under 2 business segments: the Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products; and the Medical segment distributes a range of medical, surgical and laboratory products, and p...
Chinese pharmaceutical company Shenzhou Yiqiao Information Service has divested its 100% stake in gelatin products manufacturer Qinghai Gelatin and pharmaceutical...Read More... The post M&As this week: Shenzhou Yiqiao Information Service, Walvax Biotechnology, Kangmei Pharmaceutical appeared first on Pharmaceutical Technology.
The global pharmaceutical filtration market is expected to grow at a CAGR of more than 11 % during the forecast period. The increasing prevalence of heart attacks and diabetes has increased the demand for pharmaceutical products such as antibodies, hormones, and vaccines, which further increase the adoption of pharmaceutical filtration, thereby increasing their demand.
When applied to the pharmaceutical industry, and more specifically to clinical trials, the interest of block chain technology seems obvious. Currently 53% of the population doesn't trust the pharmaceutical industry .
SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...
Singapore’s pharmaceutical market is expected to increase from $903m in 2016 to $1.15bn in 2021 in value, representing a compound...Read More... The post Report: Singapore’s pharmaceutical market to witness 5% CAGR up to 2021 appeared first on Pharmaceutical Technology.
CVC Capital Partners has launched a new specialty pharmaceutical company in the UK following the completion of its $703m acquisition of a part of Israel-based Teva Pharmaceutical Industries’ global women’s health business.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: List of top 25 biotechnology and pharmaceutical companies . List of top 25 biotechnology and pharmaceutical companies: Here, Biochem Adda team have listed top independent biotechnology and pharmaceutical … Continue reading → Cet article #jobs #lifescience List of t...
Cambridge Combinatorial Ltd., a wholly owned subsidiary of Oxford Molecular Group, has completed delivery of library compounds in their collaboration with Dainippon Pharmaceutical Co. Ltd., a Japanese pharmaceutical company...
Teva Pharmaceutical has launched the generic version of Reyataz (atazanavir) capsules in the US. Indicated for use in combination with...Read More... The post Teva Pharmaceutical launches generic version of Reyataz in US appeared first on Pharmaceutical Technology.
European Pharmaceutical ReviewCannabidiol may help to reduce seizures in Lennox-Gastaut syndromeEuropean Pharmaceutical ReviewTreatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures – seizures which involve sudden falls due to loss of muscle tone – in people with Lennox-Gastaut syndrome ...and more